Sunita D Nasta, MD
She/Her/Hers
Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Make an appointmentCall 215-615-5858
Headshot of Sunita D Nasta, MD
Penn Medicine Provider

About me

  • Chair, Clinical Trials Review Monitoring Committee
  • Committee Chair, Penn Institutional Review Board
  • Section Chief, Lymphoma, Hematology-Oncology
  • Professor of Clinical Medicine (Hematology-Oncology)

Dr Sunita Nasta has been working for a cure for lymphoma for over 20 years at the University of Pennsylvania Perelman School of Medicine. Patients and their families are the core of the battle. Working one patient at a time, she has taken her findings from the bedside back to her collaborators in the labs. From personalized diagnostics which find the specific mutations that drive lymphoma to the deficits that prevents the immune system from reacting to cancer to the challenges of survivors, she has seen the landscape change. While the war is not won, she knows that  each battle fought is one step closer. She is also a regional/national expert in the management of patients with Castleman disorder and Histiocytic disorders.

Education and training

  • Medical School: Virginia Commonwealth University
  • Residency: Baylor College of Medicine
  • Residency: Baylor College of Medicine - Ben Taub General Hospital
  • Fellowship: Baylor College of Medicine
  • Fellowship: University Texas Health Science Center San Antonio
  • Fellowship: University of Texas - MD Anderson Cancer Center

What my patients think about me

Average Rating

1074 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
always excellent service
February 2026
i love her
January 2026
she is very astute and thorough.
January 2026
best in class

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Nasta is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Carrie Thompson 1, Marek Trněný 2, Franck Morschhauser 3, Gilles Salles 4, Patrick M Reagan 5, Mark Hertzberg 6, Huilai Zhang 7, Catherine Thieblemont 8, Bei Hu 9, Gustavo Fonseca 10, Won Seog Kim 11, Maurizio Martelli 12, Amitkumar Mehta 13, Avrita Singh 14, Mark Yan 15, Jamie Hirata 14, Matthew Sugidono 14, Calvin Lee 14, Jeff P Sharman 16, Neha Mehta-Shah 17, Christopher R Flowers 18, Hervé Tilly 19, Neil Chua 20, René-Olivier Casasnovas 21, Fiona Miall 22, Tae Min Kim 23, Xavier Cheng-Hong Tsai 24, Sunita Nasta 25, Seung Tae Lee 26, Jonathan W Friedberg 5 PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study , Blood, 147(3): 2026,254-265

Elghawy O, Sussman JH, Yang AG, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. , JAMA Dermatol., 161(6): 2025 ,e250251

Ward RE, Dave N, Pai EL, Colbourn R, Banihashemi A, Nasta SD, Babatunde VD. Methotrexate-associated Peripheral Neuropathy on 18F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis. , Clin Nucl Med. : 2025 ,Online ahead of print.

Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM. The Association of Epstein-Barr Virus Donor and Recipient Serostatus With Outcomes After Kidney Transplantation : A Retrospective Cohort Study , Ann Intern Med., 178(2): 2025 ,157-166

Shah NN, Zinzani PL, Wang M, Nasta SD, Lech-Maranda E, Ogawa Y, Fakhri B, Kuss B, Miyashita K, Patel K, Coombs CC, Ma S, Patel MR, Barve MA, Tessoulin B, Stathis A, Ennishi D, Hashimoto D, Kojima K, Zelenetz AD, Cohen JB, Vose JM, Maddocks KJ, Munir T, Sun F, Bian Y, Balbas M, Tsai DE, Abada P, Cheah CY. Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study. , Blood Adv, 9(23): 2025,5954-5964

Stefan Barta, Stephen Schuster, Jakub Svoboda, Jordan Carter, Elise Chong, Daniel Landsburg, Sunita Nasta, Ruchi Patel, Joseph Fraietta, Colin Thomas, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Siciliano, Marco Ruella, Rosemary Mazanet CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T-cell non-Hodgkin lymphoma: A first-in-human phase I clinical trial (NCT06420089 , American Society of Clinical Oncology Annual Meeting, Chicago, IL. : 2025

Saishravan Shyamsundar, Larissa Borys, Sheila Pierson, Mateo Sarmiento Bustamante, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Sunita Nasta, Ariela Noy, Bridget Austin, Joshua Brandstadter, David Fajgenbaum Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2025

Nikita K. Dave, Paola Carvajal, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2025

Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure. , N Engl J Med. , 392(18): 2025,1824-1835

Nikita K. Dave, Veronica Carvajal, Alex C. Watts, Jordan S. Carter, Michael Cook, Colin Thomas, Donald E. Tsai, Stephen J. Schuster, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Wei-Ting Hwang, Daniel J. Landsburg, Sunita D. Nasta Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma , Blood Neoplasia, 2(3): 2025,100102.